Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for RCAR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 1999. Start Trial.
Date Value
September 30, 2022 -1.460M
June 30, 2022 -1.255M
March 31, 2022 0.8208M
December 31, 2021 2.347M
September 30, 2021 3.479M
June 30, 2021 4.931M
March 31, 2021 5.665M
December 31, 2020 7.079M
September 30, 2020 8.589M
June 30, 2020 10.03M
March 31, 2020 11.45M
December 31, 2019 12.16M
September 30, 2019 13.14M
June 30, 2019 14.26M
March 31, 2019 14.81M
December 31, 2018 15.33M
September 30, 2018 0.3822M
June 30, 2018 0.83M
March 31, 2018 1.248M
December 31, 2017 1.664M
September 30, 2017 0.2046M
June 30, 2017 -0.1941M
March 31, 2017 0.1138M
December 31, 2016 0.2393M
September 30, 2016 0.6013M
Date Value
June 30, 2016 0.191M
March 31, 2016 0.7172M
December 31, 2015 0.225M
September 30, 2015 0.7457M
June 30, 2015 1.024M
March 31, 2015 0.2201M
December 31, 2014 0.4743M
September 30, 2014 0.7153M
June 30, 2014 1.310M
March 31, 2014 1.563M
December 31, 2013 1.698M
September 30, 2013 0.7523M
June 30, 2013 0.8737M
March 31, 2013 0.9467M
December 31, 2012 0.9678M
September 30, 2012 1.011M
June 30, 2012 1.050M
March 31, 2012 1.128M
December 31, 2011 1.212M
September 30, 2011 0.5118M
June 30, 2011 -0.6268M
March 31, 2011 -3.383M
December 31, 2010 -3.242M
September 30, 2010 1.876M
June 30, 2010 0.9306M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Athersys, Inc. --
Marizyme, Inc. --
Mera Pharmaceuticals, Inc. --
PhaseRx, Inc. --
Aditxt, Inc. -33.28M